An RB-1 loss of function gene signature as a tool to...

Therapeutic Advances in Medical Oncology 2019 / 01 Vol. 11

An RB-1 loss of function gene signature as a tool to predict response to neoadjuvant chemotherapy plus anti-HER2 agents: a substudy of the NeoALTTO trial (BIG 1-06)

Risi, Emanuela, Biagioni, Chiara, Benelli, Matteo, Migliaccio, Ilenia, McCartney, Amelia, Bonechi, Martina, Guarducci, Cristina, Hilbers, Florentine, Di Cosimo, Serena, Huober, Jens, Romagnoli, Dario,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
11
Journal:
Therapeutic Advances in Medical Oncology
DOI:
10.1177/1758835919891608
Date:
January, 2019
File:
PDF, 791 KB
2019
Conversion to is in progress
Conversion to is failed